A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients.
Sato Y, Maeda Y, Shomura H, Sasatomi T, Takahashi M, Une Y, Kondo M, Shinohara T, Hida N, Katagiri K, Sato K, Sato M, Yamada A, Yamana H, Harada M, Itoh K, Todo S.
Sato Y, et al. Among authors: shomura h.
Br J Cancer. 2004 Apr 5;90(7):1334-42. doi: 10.1038/sj.bjc.6601711.
Br J Cancer. 2004.
PMID: 15054451
Free PMC article.
Clinical Trial.